Bisphosphonates

DRUG7 trials

Sponsors

Vanderbilt-Ingram Cancer Center, Tuen Mun Hospital, Damascus University, Sun Yat-sen University, University of California, Davis

Conditions

Breast CancerFacet Joint PainKnee OsteoarthristisMultiple MyelomaOsteogenesis ImperfectaOsteoporosisVertebral Compression Fracture

Phase 2

First Autologous Transplant on Minimal Residual Disease Markers in Previously Untreated Myeloma Undergoing Initial Treatment With Velcade

CompletedNCT01215344

Vanderbilt-Ingram Cancer CenterMultiple Myeloma

Start: 2010-11-30End: 2018-03-31Updated: 2018-05-15

Phase 4

Denosumab in Current Users of Bisphosphonates for Glucocorticoid-induced Osteoporosis

CompletedNCT01465568

Tuen Mun HospitalOsteoporosis

Start: 2011-12-31End: 2014-06-30Updated: 2015-05-12

Radiofrequency Ablation: Treatment for Posterior Element Pain From Vertebral Compression Fractures

WithdrawnNCT03651804

University of California, DavisFacet Joint Pain, Vertebral Compression Fracture

Start: 2019-04-10End: 2023-12-19Updated: 2025-07-16

Unknown Phase

Bisphosphonates Effects On Alveolar Bone Among Osteoporotic Women

CompletedNCT02115490

Damascus UniversityOsteoporosis

Start: 2014-04-30End: 2015-09-30Updated: 2015-09-29

A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Postmenopausal Breast Cancer Patients

Sun Yat-sen UniversityBreast Cancer

Start: 2018-06-15End: 2023-06-15Target: 2000Updated: 2018-06-20

Registry of Osteogenesis Imperfecta

RecruitingNCT04115774

Luca SangiorgiOsteogenesis Imperfecta

Start: 2013-06-28End: 2032-02-29Target: 5000Updated: 2025-11-20

The Effect of Long-term Use of Bisphosphonates on Femur Morphology

CompletedNCT06621069

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityKnee Osteoarthristis, Osteoporosis

Start: 2024-06-01End: 2024-08-01Updated: 2024-10-01

Related Papers

Prospective Trial of Minimal Residual Disease Assessment by Multiparametric Flow Cytometry for Multiple Myeloma in the Era of Bortezomib-Based Chemotherapy

Biology of Blood and Marrow Transplantation2018-02-03

In the Era of Bortezomib-Based Chemotherapy the Presence of Minimal Residual Disease Predicts Progression Free Survival after Autologous Hematopoietic Cell Transplant

Blood2015-12-03

Denosumab May Warrant Further Testing in Patients Receiving Long-Term GC Therapy

MD Conference Express2014-07-01